In a Dec. 23 statement, Astellas Pharma US said it has notified customers of one lot of Prograf and another lot of Astagraf XL. Prograf is prescribed to prevent rejections of kidney, heart, liver or lung transplants, while Astagraf XL is for kidney transplants.
Ingesting empty capsules could result in transplant rejection, which can be fatal for patients with life-sustaining organ transplants such as a heart. No adverse events have been reported, Astellas said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
